• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA COLLECT SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA COLLECT SET Back to Search Results
Catalog Number 12120
Device Problems Obstruction of Flow (2423); Device Displays Incorrect Message (2591); Device Operational Issue (2914)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 01/03/2017
Event Type  malfunction  
Manufacturer Narrative
Investigation: the customer stated that the ac frangible was not correctly broken by the operator.A review of the device history record (dhr) for this unit showed no irregularities during manufacturing that were relevant to this issue.Investigation is in process.A follow-up report will be provided.
 
Event Description
The customer reported that during a mononuclear cell (mnc) collection procedure, they observed clotting in the collection set.After the operator replaced the anticoagulant (ac)solution bag, she received several return line alarms.The operator checked the lines for obstructions and observed clots in the return tubing line, collection bag and observed a long strand of clots in the chamber.The procedure was discontinued and the patient was disconnected.Per the customer, the patient was infused with the clots.It is unknown at this time if medical intervention was required for this event.Patient information is not available at this time.Patient outcome is not available at this time.The mnc collection set is not available for return because it was discarded by the customer.
 
Manufacturer Narrative
Investigation: the run data file (rdf) was analyzed for this event.Review of the rdf and associated aim interface images for this procedure confirmed the presence of clumping in the connector starting approximately 180 minutes into the procedure (as calculated from the time the ¿start¿ button was pressed).The clumping persisted at a low-level and worsened approximately 40 minutes later (at 221 minutes elapsed run time).The procedure was eventually ended because the clumping led to ¿return pressure was too high¿ and ¿air was detected in return line¿ alarms.The spectra optia system is designed to monitor fluid presence in the ac line using the ac fluid detector throughout the procedure.The signals in the rdf indicate that the ac fluid detector was functioning as intended, as the sensor saw fluid in the ac line during ac prime, at the beginning of the procedure, and throughout the run.Furthermore, during ac prime, the system uses the inlet pressure sensor to verify that the ac line is not initially occluded.Once the procedure is started and patient blood and ac are brought into the manifold via the inlet and ac pumps, there is no way for the optia system to differentiate between the types of fluid being brought into the cassette.Consequently, the inlet pressure sensor is no longer able to check ac fluid presence during the procedure.There were no alarms during ac prime to suggest an occlusion was present in the ac line at the start of the procedure.It is also noted that the operator increased the inlet: ac ratio once clumping was identified.Investigation is in process.A follow-up report will be provided.
 
Event Description
Due to (b)(6) personal data protection laws, the patient information is not available from the customer.Patient's gender and weight were obtained from the run data file (rdf).
 
Manufacturer Narrative
Root cause: based on the information provided by customer and run data file analysis, the root cause for the clots was improper anticoagulant in the set due to the frangible being partially broken when the second bag was connected.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRA OPTIA
Type of Device
SPECTRA OPTIA COLLECT SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
Manufacturer Contact
steve kern
10810 w. collins ave
lakewood, CO 80215
3032392246
MDR Report Key6397297
MDR Text Key69995375
Report Number1722028-2017-00076
Device Sequence Number1
Product Code LKN
Combination Product (y/n)N
Reporter Country CodeNL
PMA/PMN Number
K153601
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Health Professional
Type of Report Initial,Followup,Followup
Report Date 03/10/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/01/2018
Device Catalogue Number12120
Device Lot Number07Z3315
Other Device ID Number05020583121201
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/14/2017
Initial Date FDA Received03/10/2017
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Supplement Dates FDA Received04/04/2017
04/26/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/26/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
ACD-A, LOT # 16063003
Patient Outcome(s) Other;
Patient Weight65
-
-